vs
GE医疗（CCRN）与莱迪思半导体（LSCC）财务数据对比。点击上方公司名可切换其他公司
GE医疗的季度营收约是莱迪思半导体的1.6倍（$236.8M vs $145.8M），莱迪思半导体净利率更高（-5.2% vs -35.0%，领先29.8%），莱迪思半导体同比增速更快（24.2% vs -23.6%），莱迪思半导体自由现金流更多（$44.0M vs $16.1M），过去两年莱迪思半导体的营收复合增速更高（1.8% vs -21.0%）
GE医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，品牌标识为GE HealthCare。公司主要业务分为四大板块：包含分子影像、CT、磁共振、妇科筛查及X光设备的医学影像业务、超声业务，以及聚焦远程患者监测、麻醉呼吸护理、心脏诊断、婴幼儿护理的患者护理解决方案业务，此外还开展医药相关业务。
莱迪思半导体是美国专注于低功耗现场可编程门阵列（FPGA）设计制造的半导体企业，1983年成立，1989年上市，总部位于俄勒冈州希尔斯伯勒硅林区，在圣何塞、上海、马尼拉、槟城、新加坡等地设有运营网点，截至2022年员工超1000人，年营收超6.6亿美元。
CCRN vs LSCC — 直观对比
营收规模更大
CCRN
是对方的1.6倍
$145.8M
营收增速更快
LSCC
高出47.8%
-23.6%
净利率更高
LSCC
高出29.8%
-35.0%
自由现金流更多
LSCC
多$27.9M
$16.1M
两年增速更快
LSCC
近两年复合增速
-21.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $236.8M | $145.8M |
| 净利润 | $-82.9M | $-7.6M |
| 毛利率 | — | 68.5% |
| 营业利润率 | -30.2% | 0.7% |
| 净利率 | -35.0% | -5.2% |
| 营收同比 | -23.6% | 24.2% |
| 净利润同比 | -2109.7% | -146.3% |
| 每股收益（稀释后） | $-2.56 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCRNLSCC
| Q1 26 | — | $145.8M | ||
| Q4 25 | $236.8M | — | ||
| Q3 25 | $250.1M | $133.3M | ||
| Q2 25 | $274.1M | $124.0M | ||
| Q1 25 | $293.4M | $120.2M | ||
| Q4 24 | $309.9M | $117.4M | ||
| Q3 24 | $315.1M | $127.1M | ||
| Q2 24 | $339.8M | $124.1M |
净利润CCRNLSCC
| Q1 26 | — | $-7.6M | ||
| Q4 25 | $-82.9M | — | ||
| Q3 25 | $-4.8M | $2.8M | ||
| Q2 25 | $-6.7M | $2.9M | ||
| Q1 25 | $-490.0K | $5.0M | ||
| Q4 24 | $-3.8M | $16.5M | ||
| Q3 24 | $2.6M | $7.2M | ||
| Q2 24 | $-16.1M | $22.6M |
毛利率CCRNLSCC
| Q1 26 | — | 68.5% | ||
| Q4 25 | — | — | ||
| Q3 25 | 20.4% | 67.9% | ||
| Q2 25 | 20.4% | 68.4% | ||
| Q1 25 | 20.0% | 68.0% | ||
| Q4 24 | — | 61.1% | ||
| Q3 24 | 20.4% | 69.0% | ||
| Q2 24 | 20.8% | 68.3% |
营业利润率CCRNLSCC
| Q1 26 | — | 0.7% | ||
| Q4 25 | -30.2% | — | ||
| Q3 25 | -2.4% | -1.2% | ||
| Q2 25 | -2.1% | 3.8% | ||
| Q1 25 | -0.3% | 5.8% | ||
| Q4 24 | -1.1% | -10.4% | ||
| Q3 24 | 0.9% | 5.9% | ||
| Q2 24 | -5.7% | 18.2% |
净利率CCRNLSCC
| Q1 26 | — | -5.2% | ||
| Q4 25 | -35.0% | — | ||
| Q3 25 | -1.9% | 2.1% | ||
| Q2 25 | -2.4% | 2.3% | ||
| Q1 25 | -0.2% | 4.2% | ||
| Q4 24 | -1.2% | 14.1% | ||
| Q3 24 | 0.8% | 5.7% | ||
| Q2 24 | -4.7% | 18.2% |
每股收益（稀释后）CCRNLSCC
| Q1 26 | — | $-0.06 | ||
| Q4 25 | $-2.56 | — | ||
| Q3 25 | $-0.15 | $0.02 | ||
| Q2 25 | $-0.20 | $0.02 | ||
| Q1 25 | $-0.02 | $0.04 | ||
| Q4 24 | $-0.13 | $0.12 | ||
| Q3 24 | $0.08 | $0.05 | ||
| Q2 24 | $-0.47 | $0.16 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $108.7M | $133.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $322.8M | $714.1M |
| 总资产 | $449.0M | $883.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CCRNLSCC
| Q1 26 | — | $133.9M | ||
| Q4 25 | $108.7M | — | ||
| Q3 25 | $99.1M | $117.9M | ||
| Q2 25 | $81.2M | $107.2M | ||
| Q1 25 | $80.7M | $127.6M | ||
| Q4 24 | $81.6M | $136.3M | ||
| Q3 24 | $64.0M | $124.3M | ||
| Q2 24 | $69.6M | $109.2M |
股东权益CCRNLSCC
| Q1 26 | — | $714.1M | ||
| Q4 25 | $322.8M | — | ||
| Q3 25 | $408.1M | $706.4M | ||
| Q2 25 | $412.2M | $687.0M | ||
| Q1 25 | $418.2M | $707.9M | ||
| Q4 24 | $419.0M | $710.9M | ||
| Q3 24 | $424.7M | $703.5M | ||
| Q2 24 | $433.3M | $698.8M |
总资产CCRNLSCC
| Q1 26 | — | $883.1M | ||
| Q4 25 | $449.0M | — | ||
| Q3 25 | $538.2M | $844.4M | ||
| Q2 25 | $553.8M | $808.6M | ||
| Q1 25 | $576.2M | $823.6M | ||
| Q4 24 | $589.3M | $843.9M | ||
| Q3 24 | $597.4M | $853.7M | ||
| Q2 24 | $602.9M | $827.5M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $18.2M | $57.6M |
| 自由现金流经营现金流 - 资本支出 | $16.1M | $44.0M |
| 自由现金流率自由现金流/营收 | 6.8% | 30.2% |
| 资本支出强度资本支出/营收 | 0.9% | 9.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $40.1M | $132.6M |
8季度趋势，按日历期对齐
经营现金流CCRNLSCC
| Q1 26 | — | $57.6M | ||
| Q4 25 | $18.2M | — | ||
| Q3 25 | $20.1M | $47.1M | ||
| Q2 25 | $4.2M | $38.5M | ||
| Q1 25 | $5.7M | $31.9M | ||
| Q4 24 | $24.2M | $45.4M | ||
| Q3 24 | $7.5M | $44.0M | ||
| Q2 24 | $82.4M | $21.9M |
自由现金流CCRNLSCC
| Q1 26 | — | $44.0M | ||
| Q4 25 | $16.1M | — | ||
| Q3 25 | $17.9M | $34.0M | ||
| Q2 25 | $2.3M | $31.3M | ||
| Q1 25 | $3.8M | $23.3M | ||
| Q4 24 | $21.7M | $39.7M | ||
| Q3 24 | $6.3M | $39.4M | ||
| Q2 24 | $79.6M | $14.8M |
自由现金流率CCRNLSCC
| Q1 26 | — | 30.2% | ||
| Q4 25 | 6.8% | — | ||
| Q3 25 | 7.2% | 25.5% | ||
| Q2 25 | 0.8% | 25.2% | ||
| Q1 25 | 1.3% | 19.4% | ||
| Q4 24 | 7.0% | 33.8% | ||
| Q3 24 | 2.0% | 31.0% | ||
| Q2 24 | 23.4% | 11.9% |
资本支出强度CCRNLSCC
| Q1 26 | — | 9.3% | ||
| Q4 25 | 0.9% | — | ||
| Q3 25 | 0.9% | 9.8% | ||
| Q2 25 | 0.7% | 5.8% | ||
| Q1 25 | 0.6% | 7.2% | ||
| Q4 24 | 0.8% | 4.9% | ||
| Q3 24 | 0.4% | 3.7% | ||
| Q2 24 | 0.8% | 5.8% |
现金转化率CCRNLSCC
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 16.86× | ||
| Q2 25 | — | 13.23× | ||
| Q1 25 | — | 6.35× | ||
| Q4 24 | — | 2.75× | ||
| Q3 24 | 2.92× | 6.12× | ||
| Q2 24 | — | 0.97× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
LSCC
| Asia | $106.3M | 73% |
| Americas | $21.0M | 14% |
| Europe | $18.5M | 13% |
